标题/作者	年份
Estimating the burden of SARS-CoV-2 in France H Salje, C Tran Kiem, N Lefrancq, N Courtejoie, P Bosetti, J Paireau, ... Science 369 (6500), 208-211	2020
Humoral immune response to SARS-CoV-2 in Iceland DF Gudbjartsson, GL Norddahl, P Melsted, K Gunnarsdottir, H Holm, ... New England Journal of Medicine 383 (18), 1724-1734	2020
SARS-CoV-2 (COVID-19) by the numbers YM Bar-On, A Flamholz, R Phillips, R Milo elife 9, e57309	2020
Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study NG Davies, AJ Kucharski, RM Eggo, A Gimma, WJ Edmunds, T Jombart, ... The Lancet Public Health 5 (7), e375-e385	2020
Evolution and epidemic spread of SARS-CoV-2 in Brazil DS Candido, IM Claro, JG De Jesus, WM Souza, FRR Moreira, ... Science 369 (6508), 1255-1260	2020
Mobilizing policy (in) capacity to fight COVID-19: Understanding variations in state responses G Capano, M Howlett, DSL Jarvis, M Ramesh, N Goyal Policy and Society 39 (3), 285-308	2020
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates G Meyerowitz-Katz, L Merone International Journal of Infectious Diseases 101, 138-148	2020
Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review KL Chai, SJ Valk, V Piechotta, C Kimber, I Monsef, C Doree, EM Wood, ... Cochrane Database of Systematic Reviews	2020
Real-time forecasts and risk assessment of novel coronavirus (COVID-19) cases: A data-driven analysis T Chakraborty, I Ghosh Chaos, Solitons & Fractals 135, 109850	2020
Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile GE Mena, PP Martinez, AS Mahmud, PA Marquet, CO Buckee, ... Science 372 (6545), eabg5298	2021
Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases AW Byrne, D McEvoy, AB Collins, K Hunt, M Casey, A Barber, F Butler, ... BMJ open 10 (8), e039856	2020
Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK L Du Plessis, JT McCrone, AE Zarebski, V Hill, C Ruis, B Gutierrez, ... Science 371 (6530), 708-712	2021
Coronavirus disease 2019 in patients with inborn errors of immunity: an international study I Meyts, G Bucciol, I Quinti, B Neven, A Fischer, E Seoane, ... Journal of Allergy and Clinical Immunology 147 (2), 520-531	2021
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic KKW To, S Sridhar, KHY Chiu, DLL Hung, X Li, IFN Hung, AR Tam, ... Emerging microbes & infections 10 (1), 507-535	2021
Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland J Perez-Saez, SA Lauer, L Kaiser, S Regard, E Delaporte, I Guessous, ... The Lancet Infectious Diseases 21 (4), e69-e70	2021
Fundamental principles of epidemic spread highlight the immediate need for large-scale serological surveys to assess the stage of the SARS-CoV-2 epidemic J Lourenco, R Paton, M Ghafari, M Kraemer, C Thompson, P Simmonds, ... MedRxiv, 2020.03. 24.20042291	2020
COVID-19 control in low-income settings and displaced populations: what can realistically be done? M Dahab, K Van Zandvoort, S Flasche, A Warsame, R Ratnayake, ... Conflict and health 14 (1), 1-6	2020
Population point prevalence of SARS-CoV-2 infection based on a statewide random sample—Indiana, April 25–29, 2020 N Menachemi, CT Yiannoutsos, BE Dixon, TJ Duszynski, WF Fadel, ... Morbidity and Mortality Weekly Report 69 (29), 960	2020
Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis W Yang, S Kandula, M Huynh, SK Greene, G Van Wye, W Li, HT Chan, ... The Lancet Infectious Diseases 21 (2), 203-212	2021
COVID-19 case-fatality rate and demographic and socioeconomic influencers: worldwide spatial regression analysis based on country-level data Y Cao, A Hiyoshi, S Montgomery BMJ open 10 (11), e043560	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。